However, there was no significant difference in liver-weight-to-body ratio, liver injury, histological changes, HCC markers, or cell proliferation between OGA-KO and control mice treated with DEN (Figure 5H and Supplemental Figure S4C–K, http://links.lww.com/HC9/A576). This evidence concerns the gene OGA and hepatocellular carcinoma.